VTCN1 and central nervous system cancer: By exploring the B7-H4 level in glioma tissues with different grades, Yao and their colleagues found that the cross-talk between glioma-initiating cells and macrophages mediated by B7-H4 through the IL6/JAK/STAT3 pathway could result in poor prognosis [23].